Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle exocytosis (GO:0016079) | 5.97105106 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.96231541 |
3 | vocalization behavior (GO:0071625) | 5.48302998 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.47559079 |
5 | glutamate secretion (GO:0014047) | 5.44067502 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.27098695 |
7 | synaptic vesicle maturation (GO:0016188) | 5.25079805 |
8 | protein localization to synapse (GO:0035418) | 5.12586179 |
9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.12033194 |
10 | locomotory exploration behavior (GO:0035641) | 4.96388010 |
11 | neuron cell-cell adhesion (GO:0007158) | 4.88887185 |
12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.86951531 |
13 | * regulation of synaptic vesicle exocytosis (GO:2000300) | 4.77735889 |
14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.74259565 |
15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.64146806 |
16 | L-amino acid import (GO:0043092) | 4.58773321 |
17 | neuronal action potential propagation (GO:0019227) | 4.53760667 |
18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.53393880 |
19 | neurotransmitter secretion (GO:0007269) | 4.51389336 |
20 | glutamate receptor signaling pathway (GO:0007215) | 4.34519863 |
21 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.28090203 |
22 | * regulation of synaptic vesicle transport (GO:1902803) | 4.27188200 |
23 | cell communication by electrical coupling (GO:0010644) | 4.23421924 |
24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.23274735 |
25 | cellular potassium ion homeostasis (GO:0030007) | 4.22755416 |
26 | potassium ion homeostasis (GO:0055075) | 4.22322545 |
27 | exploration behavior (GO:0035640) | 4.19581072 |
28 | cellular sodium ion homeostasis (GO:0006883) | 4.16501794 |
29 | * neuron-neuron synaptic transmission (GO:0007270) | 4.13899283 |
30 | potassium ion import (GO:0010107) | 4.11206504 |
31 | amino acid import (GO:0043090) | 4.11190005 |
32 | positive regulation of synapse maturation (GO:0090129) | 4.09557966 |
33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.07970380 |
34 | synaptic vesicle endocytosis (GO:0048488) | 3.99769400 |
35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.99689072 |
36 | neuronal ion channel clustering (GO:0045161) | 3.96931827 |
37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.95831883 |
38 | * synaptic transmission, glutamatergic (GO:0035249) | 3.91943077 |
39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.87387282 |
40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.84544705 |
41 | neurotransmitter transport (GO:0006836) | 3.83963170 |
42 | long-term memory (GO:0007616) | 3.79819805 |
43 | long-term synaptic potentiation (GO:0060291) | 3.76949624 |
44 | regulation of synapse structural plasticity (GO:0051823) | 3.75962603 |
45 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.74230417 |
46 | positive regulation of membrane potential (GO:0045838) | 3.72370735 |
47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.72264945 |
48 | layer formation in cerebral cortex (GO:0021819) | 3.71321883 |
49 | axon ensheathment in central nervous system (GO:0032291) | 3.68997734 |
50 | central nervous system myelination (GO:0022010) | 3.68997734 |
51 | positive regulation of dendritic spine development (GO:0060999) | 3.68091074 |
52 | proline transport (GO:0015824) | 3.67613917 |
53 | response to histamine (GO:0034776) | 3.66558418 |
54 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.64144746 |
55 | neuromuscular process controlling balance (GO:0050885) | 3.63541367 |
56 | gamma-aminobutyric acid transport (GO:0015812) | 3.60593456 |
57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.56941960 |
58 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.56732616 |
59 | neuron recognition (GO:0008038) | 3.54660789 |
60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.52975629 |
61 | presynaptic membrane assembly (GO:0097105) | 3.48164873 |
62 | neurotransmitter uptake (GO:0001504) | 3.46717025 |
63 | regulation of synaptic plasticity (GO:0048167) | 3.46095474 |
64 | regulation of neurotransmitter levels (GO:0001505) | 3.46059024 |
65 | regulation of vesicle fusion (GO:0031338) | 3.43466893 |
66 | * regulation of neurotransmitter secretion (GO:0046928) | 3.42087904 |
67 | postsynaptic membrane organization (GO:0001941) | 3.39261776 |
68 | cell communication involved in cardiac conduction (GO:0086065) | 3.39154351 |
69 | regulation of ARF protein signal transduction (GO:0032012) | 3.38763558 |
70 | auditory behavior (GO:0031223) | 3.35725527 |
71 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.35423921 |
72 | positive regulation of neurotransmitter transport (GO:0051590) | 3.31434365 |
73 | behavioral response to cocaine (GO:0048148) | 3.30347019 |
74 | transmission of nerve impulse (GO:0019226) | 3.29256317 |
75 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.28390633 |
76 | acidic amino acid transport (GO:0015800) | 3.28235441 |
77 | innervation (GO:0060384) | 3.27271591 |
78 | regulation of synapse maturation (GO:0090128) | 3.26718117 |
79 | detection of calcium ion (GO:0005513) | 3.26562969 |
80 | regulation of dendritic spine development (GO:0060998) | 3.25608029 |
81 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.25526537 |
82 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.24142953 |
83 | neuromuscular synaptic transmission (GO:0007274) | 3.24020412 |
84 | dendritic spine morphogenesis (GO:0060997) | 3.23951340 |
85 | behavioral defense response (GO:0002209) | 3.23591276 |
86 | behavioral fear response (GO:0001662) | 3.23591276 |
87 | presynaptic membrane organization (GO:0097090) | 3.23071219 |
88 | membrane hyperpolarization (GO:0060081) | 3.22785510 |
89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.22011711 |
90 | activation of protein kinase A activity (GO:0034199) | 3.20912288 |
91 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.20686362 |
92 | * regulation of neurotransmitter transport (GO:0051588) | 3.20050578 |
93 | membrane depolarization (GO:0051899) | 3.19586213 |
94 | neuromuscular process controlling posture (GO:0050884) | 3.19104308 |
95 | sodium ion export (GO:0071436) | 3.18746036 |
96 | synapse assembly (GO:0007416) | 3.17325225 |
97 | synaptic vesicle transport (GO:0048489) | 3.16435677 |
98 | establishment of synaptic vesicle localization (GO:0097480) | 3.16435677 |
99 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.14651534 |
100 | mating behavior (GO:0007617) | 3.14190385 |
101 | membrane depolarization during action potential (GO:0086010) | 3.13900636 |
102 | * synaptic transmission (GO:0007268) | 3.13362536 |
103 | vesicle docking involved in exocytosis (GO:0006904) | 3.13271525 |
104 | fear response (GO:0042596) | 3.11383116 |
105 | positive regulation of synaptic transmission (GO:0050806) | 3.10404661 |
106 | axonal fasciculation (GO:0007413) | 3.09252321 |
107 | learning (GO:0007612) | 3.08174545 |
108 | long term synaptic depression (GO:0060292) | 3.07423322 |
109 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.06767889 |
110 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.06644892 |
111 | neuromuscular process (GO:0050905) | 3.06474810 |
112 | startle response (GO:0001964) | 3.05240561 |
113 | cell differentiation in hindbrain (GO:0021533) | 3.02678734 |
114 | establishment of mitochondrion localization (GO:0051654) | 3.02017973 |
115 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.00311191 |
116 | dendritic spine organization (GO:0097061) | 2.99546928 |
117 | cerebellar granule cell differentiation (GO:0021707) | 2.97526078 |
118 | * regulation of synaptic transmission (GO:0050804) | 2.97180867 |
119 | striatum development (GO:0021756) | 2.97098156 |
120 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.96866927 |
121 | response to auditory stimulus (GO:0010996) | 2.96116077 |
122 | vesicle transport along microtubule (GO:0047496) | 2.92420296 |
123 | prepulse inhibition (GO:0060134) | 2.91116331 |
124 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.89552622 |
125 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.89229903 |
126 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.89222190 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.88777474 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.08505129 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16791783 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05338573 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02777473 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79269822 |
7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.61651834 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.60877468 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.60877468 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58602483 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54014085 |
12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46178221 |
13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44631607 |
14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42259526 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39309676 |
16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.35835661 |
17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33421423 |
18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27521773 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27373093 |
20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23823239 |
21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16672929 |
22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.14312016 |
23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13232027 |
24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07588104 |
25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07422747 |
26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04054434 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98635652 |
28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96428029 |
29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.93049106 |
30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92934564 |
31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89853105 |
32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85821310 |
33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85092584 |
34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.80618731 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75812868 |
36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64939519 |
37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.64652237 |
38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63818300 |
39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58977225 |
40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52530969 |
41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50232327 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42862120 |
43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41796257 |
44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41317348 |
45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41192183 |
46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40853064 |
47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40553905 |
48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39138001 |
49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38259311 |
50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38125602 |
51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37340482 |
52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36098335 |
53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35367252 |
54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35277645 |
55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35133695 |
56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34422584 |
57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32880823 |
58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32733731 |
59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31059254 |
60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30799317 |
61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30610470 |
62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29687346 |
63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26113754 |
64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22239783 |
65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20574811 |
66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19739989 |
67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18998733 |
68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18977445 |
69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18594134 |
70 | AR_19668381_ChIP-Seq_PC3_Human | 1.18444601 |
71 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18065845 |
72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13961629 |
73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11729501 |
74 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11324663 |
75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11064380 |
76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09088544 |
77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07897234 |
78 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.06691317 |
79 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05524518 |
80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05123497 |
81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05041494 |
82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04796337 |
83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04685188 |
84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04586012 |
85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03296804 |
86 | JUN_21703547_ChIP-Seq_K562_Human | 1.02691961 |
87 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00760097 |
88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00073159 |
89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99739416 |
90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98848617 |
91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98837206 |
92 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98236074 |
93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98012269 |
94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97140807 |
95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96842058 |
96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96771239 |
97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96503851 |
98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95932369 |
99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95657694 |
100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92728472 |
101 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92716918 |
102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92250032 |
103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92146607 |
104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91824869 |
105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91824869 |
106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91035800 |
107 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90299510 |
108 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90069873 |
109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89472095 |
110 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88911543 |
111 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87473493 |
112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87213564 |
113 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87168290 |
114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85439650 |
115 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84949623 |
116 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81948885 |
117 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.81844254 |
118 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81567344 |
119 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77957910 |
120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77338919 |
121 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.76689997 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.83452105 |
2 | MP0003880_abnormal_central_pattern | 5.23316938 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.06802744 |
4 | MP0004270_analgesia | 3.48031897 |
5 | MP0009745_abnormal_behavioral_response | 3.43559171 |
6 | MP0009046_muscle_twitch | 3.34634113 |
7 | MP0001968_abnormal_touch/_nociception | 3.27724432 |
8 | MP0002063_abnormal_learning/memory/cond | 3.26606279 |
9 | MP0002064_seizures | 3.24039778 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.84331495 |
11 | MP0002272_abnormal_nervous_system | 2.73426513 |
12 | MP0002734_abnormal_mechanical_nocicepti | 2.68561362 |
13 | MP0002736_abnormal_nociception_after | 2.68408443 |
14 | MP0002822_catalepsy | 2.66078653 |
15 | MP0001486_abnormal_startle_reflex | 2.51855661 |
16 | MP0002735_abnormal_chemical_nociception | 2.50317254 |
17 | MP0005423_abnormal_somatic_nervous | 2.49404208 |
18 | MP0001501_abnormal_sleep_pattern | 2.46749441 |
19 | MP0001440_abnormal_grooming_behavior | 2.24016461 |
20 | MP0002067_abnormal_sensory_capabilities | 2.17505276 |
21 | MP0006276_abnormal_autonomic_nervous | 2.08691055 |
22 | MP0002733_abnormal_thermal_nociception | 2.01191304 |
23 | MP0001970_abnormal_pain_threshold | 2.00022672 |
24 | MP0001984_abnormal_olfaction | 1.97944159 |
25 | MP0002184_abnormal_innervation | 1.90358580 |
26 | MP0005386_behavior/neurological_phenoty | 1.83308790 |
27 | MP0004924_abnormal_behavior | 1.83308790 |
28 | MP0008569_lethality_at_weaning | 1.80734849 |
29 | MP0005551_abnormal_eye_electrophysiolog | 1.79607915 |
30 | MP0002557_abnormal_social/conspecific_i | 1.70615443 |
31 | MP0001529_abnormal_vocalization | 1.69709298 |
32 | MP0003329_amyloid_beta_deposits | 1.68370998 |
33 | MP0000778_abnormal_nervous_system | 1.65143262 |
34 | MP0004811_abnormal_neuron_physiology | 1.64680696 |
35 | MP0003879_abnormal_hair_cell | 1.63973103 |
36 | MP0005646_abnormal_pituitary_gland | 1.61065824 |
37 | MP0002909_abnormal_adrenal_gland | 1.60091820 |
38 | MP0009780_abnormal_chondrocyte_physiolo | 1.59302079 |
39 | MP0004858_abnormal_nervous_system | 1.53379562 |
40 | MP0001905_abnormal_dopamine_level | 1.51999888 |
41 | MP0001188_hyperpigmentation | 1.51277466 |
42 | MP0003787_abnormal_imprinting | 1.48161574 |
43 | MP0001502_abnormal_circadian_rhythm | 1.46441043 |
44 | MP0000955_abnormal_spinal_cord | 1.44237998 |
45 | MP0010386_abnormal_urinary_bladder | 1.44204457 |
46 | MP0002882_abnormal_neuron_morphology | 1.43876924 |
47 | MP0002066_abnormal_motor_capabilities/c | 1.39683921 |
48 | MP0004142_abnormal_muscle_tone | 1.36690936 |
49 | MP0004147_increased_porphyrin_level | 1.36410612 |
50 | MP0003123_paternal_imprinting | 1.28377876 |
51 | MP0003122_maternal_imprinting | 1.27397967 |
52 | MP0003633_abnormal_nervous_system | 1.25513795 |
53 | MP0002837_dystrophic_cardiac_calcinosis | 1.23521043 |
54 | MP0005645_abnormal_hypothalamus_physiol | 1.16065678 |
55 | MP0002229_neurodegeneration | 1.15769184 |
56 | MP0008872_abnormal_physiological_respon | 1.13227203 |
57 | MP0003631_nervous_system_phenotype | 1.07859039 |
58 | MP0004145_abnormal_muscle_electrophysio | 1.07400940 |
59 | MP0004885_abnormal_endolymph | 1.07298263 |
60 | MP0002090_abnormal_vision | 1.06911621 |
61 | MP0000751_myopathy | 1.05288770 |
62 | MP0005499_abnormal_olfactory_system | 1.01784153 |
63 | MP0005394_taste/olfaction_phenotype | 1.01784153 |
64 | MP0002152_abnormal_brain_morphology | 1.01476940 |
65 | MP0002638_abnormal_pupillary_reflex | 0.96957645 |
66 | MP0008877_abnormal_DNA_methylation | 0.94721271 |
67 | MP0004742_abnormal_vestibular_system | 0.94056044 |
68 | MP0008874_decreased_physiological_sensi | 0.91176455 |
69 | MP0002752_abnormal_somatic_nervous | 0.90683624 |
70 | MP0001348_abnormal_lacrimal_gland | 0.89970362 |
71 | MP0006072_abnormal_retinal_apoptosis | 0.89546190 |
72 | MP0002069_abnormal_eating/drinking_beha | 0.89402907 |
73 | MP0001963_abnormal_hearing_physiology | 0.89292604 |
74 | MP0005535_abnormal_body_temperature | 0.86481852 |
75 | MP0001485_abnormal_pinna_reflex | 0.86352948 |
76 | MP0001986_abnormal_taste_sensitivity | 0.86075806 |
77 | MP0004215_abnormal_myocardial_fiber | 0.85459511 |
78 | MP0000569_abnormal_digit_pigmentation | 0.84705662 |
79 | MP0004233_abnormal_muscle_weight | 0.84287142 |
80 | MP0000013_abnormal_adipose_tissue | 0.84234111 |
81 | MP0003121_genomic_imprinting | 0.83504546 |
82 | MP0004085_abnormal_heartbeat | 0.80689274 |
83 | MP0005253_abnormal_eye_physiology | 0.78548178 |
84 | MP0002876_abnormal_thyroid_physiology | 0.78265147 |
85 | MP0003634_abnormal_glial_cell | 0.76915056 |
86 | MP0004484_altered_response_of | 0.76548692 |
87 | MP0000631_abnormal_neuroendocrine_gland | 0.74874899 |
88 | MP0001177_atelectasis | 0.74563365 |
89 | MP0003632_abnormal_nervous_system | 0.73113909 |
90 | MP0001664_abnormal_digestion | 0.70542193 |
91 | MP0001346_abnormal_lacrimal_gland | 0.68911112 |
92 | MP0000604_amyloidosis | 0.68725880 |
93 | MP0005409_darkened_coat_color | 0.67658157 |
94 | MP0005167_abnormal_blood-brain_barrier | 0.61345200 |
95 | MP0005623_abnormal_meninges_morphology | 0.56592477 |
96 | MP0010768_mortality/aging | 0.56066972 |
97 | MP0000920_abnormal_myelination | 0.55130138 |
98 | MP0003646_muscle_fatigue | 0.54386794 |
99 | MP0001943_abnormal_respiration | 0.54344359 |
100 | MP0003861_abnormal_nervous_system | 0.53539402 |
101 | MP0005195_abnormal_posterior_eye | 0.53305554 |
102 | MP0004130_abnormal_muscle_cell | 0.51987942 |
103 | MP0004043_abnormal_pH_regulation | 0.51673047 |
104 | MP0006292_abnormal_olfactory_placode | 0.51449741 |
105 | MP0003690_abnormal_glial_cell | 0.50673325 |
106 | MP0003137_abnormal_impulse_conducting | 0.50451585 |
107 | MP0000026_abnormal_inner_ear | 0.49599270 |
108 | MP0010769_abnormal_survival | 0.49324312 |
109 | MP0002082_postnatal_lethality | 0.49278801 |
110 | MP0010770_preweaning_lethality | 0.49278801 |
111 | MP0003956_abnormal_body_size | 0.49159955 |
112 | MP0004036_abnormal_muscle_relaxation | 0.47909357 |
113 | MP0003172_abnormal_lysosome_physiology | 0.47127819 |
114 | MP0003075_altered_response_to | 0.46878942 |
115 | MP0001299_abnormal_eye_distance/ | 0.46385017 |
116 | MP0003938_abnormal_ear_development | 0.43835943 |
117 | MP0000579_abnormal_nail_morphology | 0.43633705 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.16112221 |
2 | Myokymia (HP:0002411) | 6.06396479 |
3 | Focal seizures (HP:0007359) | 5.82034296 |
4 | Epileptic encephalopathy (HP:0200134) | 5.55306527 |
5 | Visual hallucinations (HP:0002367) | 5.31447965 |
6 | Atonic seizures (HP:0010819) | 5.31027933 |
7 | Febrile seizures (HP:0002373) | 5.21716009 |
8 | Absence seizures (HP:0002121) | 4.87464136 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.64929378 |
10 | Dialeptic seizures (HP:0011146) | 4.43052730 |
11 | Generalized tonic-clonic seizures (HP:0002069) | 4.17093174 |
12 | Hyperventilation (HP:0002883) | 3.81767416 |
13 | Broad-based gait (HP:0002136) | 3.51942988 |
14 | Action tremor (HP:0002345) | 3.46594813 |
15 | Gaze-evoked nystagmus (HP:0000640) | 3.46487678 |
16 | Truncal ataxia (HP:0002078) | 3.28651419 |
17 | Supranuclear gaze palsy (HP:0000605) | 3.27398252 |
18 | Cerebral hypomyelination (HP:0006808) | 3.24808267 |
19 | Dysdiadochokinesis (HP:0002075) | 3.19744985 |
20 | Poor eye contact (HP:0000817) | 3.08356444 |
21 | Obstructive sleep apnea (HP:0002870) | 3.05392693 |
22 | Amblyopia (HP:0000646) | 3.04999716 |
23 | Depression (HP:0000716) | 3.03421471 |
24 | Annular pancreas (HP:0001734) | 2.99889509 |
25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.94668225 |
26 | Tetraplegia (HP:0002445) | 2.92296557 |
27 | Anxiety (HP:0000739) | 2.89437942 |
28 | Dysmetria (HP:0001310) | 2.87871820 |
29 | Epileptiform EEG discharges (HP:0011182) | 2.87050186 |
30 | Abnormal eating behavior (HP:0100738) | 2.86676866 |
31 | Impaired social interactions (HP:0000735) | 2.82177570 |
32 | Abnormal social behavior (HP:0012433) | 2.82177570 |
33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.80287890 |
34 | Ankle clonus (HP:0011448) | 2.77913874 |
35 | Drooling (HP:0002307) | 2.77346233 |
36 | Excessive salivation (HP:0003781) | 2.77346233 |
37 | Akinesia (HP:0002304) | 2.76714205 |
38 | EEG with generalized epileptiform discharges (HP:0011198) | 2.70337000 |
39 | Congenital stationary night blindness (HP:0007642) | 2.69819725 |
40 | Mutism (HP:0002300) | 2.69125294 |
41 | Progressive inability to walk (HP:0002505) | 2.66994473 |
42 | Postural instability (HP:0002172) | 2.66661988 |
43 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.65641746 |
44 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.65641746 |
45 | Pheochromocytoma (HP:0002666) | 2.64707298 |
46 | Central scotoma (HP:0000603) | 2.62112034 |
47 | Limb dystonia (HP:0002451) | 2.60813954 |
48 | Sleep apnea (HP:0010535) | 2.60692627 |
49 | Absent speech (HP:0001344) | 2.56014311 |
50 | Clonus (HP:0002169) | 2.54160993 |
51 | Impaired smooth pursuit (HP:0007772) | 2.53889050 |
52 | Cerebral inclusion bodies (HP:0100314) | 2.50818485 |
53 | Abnormality of binocular vision (HP:0011514) | 2.50765308 |
54 | Diplopia (HP:0000651) | 2.50765308 |
55 | Scanning speech (HP:0002168) | 2.50083550 |
56 | Inability to walk (HP:0002540) | 2.46715886 |
57 | Hemiparesis (HP:0001269) | 2.45472074 |
58 | Fetal akinesia sequence (HP:0001989) | 2.45438471 |
59 | Gait imbalance (HP:0002141) | 2.44526313 |
60 | Peripheral hypomyelination (HP:0007182) | 2.43820947 |
61 | Bradykinesia (HP:0002067) | 2.43629597 |
62 | Genetic anticipation (HP:0003743) | 2.40645378 |
63 | Polyphagia (HP:0002591) | 2.40500217 |
64 | Dysmetric saccades (HP:0000641) | 2.38169696 |
65 | Termporal pattern (HP:0011008) | 2.37614815 |
66 | Insidious onset (HP:0003587) | 2.37614815 |
67 | Hypsarrhythmia (HP:0002521) | 2.35824054 |
68 | Status epilepticus (HP:0002133) | 2.35615710 |
69 | Neuroendocrine neoplasm (HP:0100634) | 2.34862292 |
70 | Apathy (HP:0000741) | 2.33908599 |
71 | Abnormality of macular pigmentation (HP:0008002) | 2.32188514 |
72 | Urinary urgency (HP:0000012) | 2.30209433 |
73 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.29955007 |
74 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28165549 |
75 | Abnormality of the lower motor neuron (HP:0002366) | 2.27618267 |
76 | Neurofibrillary tangles (HP:0002185) | 2.25369756 |
77 | Spastic tetraparesis (HP:0001285) | 2.24836979 |
78 | Spastic gait (HP:0002064) | 2.24236688 |
79 | Amyotrophic lateral sclerosis (HP:0007354) | 2.23983771 |
80 | CNS hypomyelination (HP:0003429) | 2.19868808 |
81 | Generalized myoclonic seizures (HP:0002123) | 2.17317680 |
82 | Torticollis (HP:0000473) | 2.15359002 |
83 | Choreoathetosis (HP:0001266) | 2.15163830 |
84 | Papilledema (HP:0001085) | 2.13212804 |
85 | Diminished motivation (HP:0000745) | 2.12773922 |
86 | Congenital primary aphakia (HP:0007707) | 2.12637141 |
87 | Stereotypic behavior (HP:0000733) | 2.11580830 |
88 | Delusions (HP:0000746) | 2.08643922 |
89 | Focal dystonia (HP:0004373) | 2.06331511 |
90 | Impaired vibratory sensation (HP:0002495) | 2.04486656 |
91 | Abnormality of the corticospinal tract (HP:0002492) | 2.04034311 |
92 | Insomnia (HP:0100785) | 2.03374194 |
93 | Rapidly progressive (HP:0003678) | 2.00564578 |
94 | Medial flaring of the eyebrow (HP:0010747) | 1.99368980 |
95 | Incomplete penetrance (HP:0003829) | 1.98636067 |
96 | Gait ataxia (HP:0002066) | 1.98189870 |
97 | Blue irides (HP:0000635) | 1.97322023 |
98 | Hemiplegia (HP:0002301) | 1.96824861 |
99 | Protruding tongue (HP:0010808) | 1.95977781 |
100 | Lower limb muscle weakness (HP:0007340) | 1.95954458 |
101 | Hypoventilation (HP:0002791) | 1.94676606 |
102 | Specific learning disability (HP:0001328) | 1.94572531 |
103 | Nephrogenic diabetes insipidus (HP:0009806) | 1.93452710 |
104 | Intention tremor (HP:0002080) | 1.91849816 |
105 | Spastic tetraplegia (HP:0002510) | 1.91646163 |
106 | Abnormal hair whorl (HP:0010721) | 1.91005048 |
107 | Increased circulating renin level (HP:0000848) | 1.89324865 |
108 | Ventricular fibrillation (HP:0001663) | 1.88644589 |
109 | Failure to thrive in infancy (HP:0001531) | 1.86775794 |
110 | Abnormality of salivation (HP:0100755) | 1.86730158 |
111 | Memory impairment (HP:0002354) | 1.86362422 |
112 | Abnormality of saccadic eye movements (HP:0000570) | 1.85560261 |
113 | Agitation (HP:0000713) | 1.84175303 |
114 | Split foot (HP:0001839) | 1.84012531 |
115 | Craniofacial dystonia (HP:0012179) | 1.81372107 |
116 | Psychosis (HP:0000709) | 1.81273332 |
117 | Retinal dysplasia (HP:0007973) | 1.78200657 |
118 | Horizontal nystagmus (HP:0000666) | 1.77794954 |
119 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.77742144 |
120 | Genital tract atresia (HP:0001827) | 1.77065808 |
121 | Megalencephaly (HP:0001355) | 1.77019958 |
122 | Esotropia (HP:0000565) | 1.75522239 |
123 | Paraplegia (HP:0010550) | 1.74000633 |
124 | Rigidity (HP:0002063) | 1.73846858 |
125 | Bundle branch block (HP:0011710) | 1.73391278 |
126 | Vaginal atresia (HP:0000148) | 1.72743883 |
127 | Widely spaced teeth (HP:0000687) | 1.71895461 |
128 | Neuronal loss in central nervous system (HP:0002529) | 1.70583821 |
129 | Heterochromia iridis (HP:0001100) | 1.70245849 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.23940717 |
2 | EPHA4 | 3.91961428 |
3 | MAP3K9 | 3.54030050 |
4 | MAP3K4 | 3.51775142 |
5 | MAP2K7 | 3.13671492 |
6 | CASK | 2.94694441 |
7 | MAP3K12 | 2.80325508 |
8 | MINK1 | 2.77878336 |
9 | MARK1 | 2.57538172 |
10 | DAPK2 | 2.27775986 |
11 | MAP2K4 | 2.24149112 |
12 | RIPK4 | 2.23054768 |
13 | PAK6 | 2.15629671 |
14 | PLK2 | 1.88552196 |
15 | KSR2 | 1.87126160 |
16 | PNCK | 1.82703195 |
17 | CDK19 | 1.81962952 |
18 | GRK5 | 1.76659548 |
19 | NTRK1 | 1.71800633 |
20 | NTRK2 | 1.70590853 |
21 | DAPK1 | 1.68245284 |
22 | ARAF | 1.59297943 |
23 | PRPF4B | 1.52145440 |
24 | CAMKK1 | 1.50088171 |
25 | KSR1 | 1.47799660 |
26 | CDK5 | 1.43069802 |
27 | MAP3K13 | 1.29710879 |
28 | FES | 1.27820746 |
29 | TNIK | 1.27471148 |
30 | STK38 | 1.26849886 |
31 | CAMKK2 | 1.25488270 |
32 | PRKCG | 1.23622511 |
33 | PRKD3 | 1.21060790 |
34 | MAPK13 | 1.20417492 |
35 | NME1 | 1.17187899 |
36 | CAMK2A | 1.13845415 |
37 | RIPK1 | 1.06880231 |
38 | SIK2 | 1.06324534 |
39 | OXSR1 | 1.04325125 |
40 | BMPR2 | 1.00110256 |
41 | PTK2B | 0.97085674 |
42 | SGK223 | 0.93241240 |
43 | SGK494 | 0.93241240 |
44 | AKT3 | 0.92240275 |
45 | UHMK1 | 0.90301976 |
46 | PHKG1 | 0.89526974 |
47 | PHKG2 | 0.89526974 |
48 | CDK14 | 0.87726427 |
49 | CDK18 | 0.87620635 |
50 | CAMK2B | 0.87050222 |
51 | CAMK1 | 0.85574441 |
52 | DYRK1A | 0.85114758 |
53 | CDK15 | 0.83967816 |
54 | MAP3K2 | 0.82998118 |
55 | PINK1 | 0.81806109 |
56 | LATS2 | 0.81595173 |
57 | SGK2 | 0.80592506 |
58 | ALK | 0.80356986 |
59 | NEK6 | 0.77865348 |
60 | RAF1 | 0.77438816 |
61 | MAPK12 | 0.74798591 |
62 | CDK11A | 0.72330741 |
63 | STK11 | 0.69643572 |
64 | PKN1 | 0.67214035 |
65 | CCNB1 | 0.67078235 |
66 | CAMK2D | 0.66760362 |
67 | RET | 0.66676046 |
68 | NEK1 | 0.66646450 |
69 | TNK2 | 0.65386986 |
70 | PAK3 | 0.63397921 |
71 | PRKCE | 0.63371692 |
72 | SGK1 | 0.62902428 |
73 | CSNK1G2 | 0.62430765 |
74 | LIMK1 | 0.62357904 |
75 | FGR | 0.61940787 |
76 | MAP3K6 | 0.59939121 |
77 | FER | 0.59201165 |
78 | PRKCH | 0.56536298 |
79 | BRAF | 0.55903767 |
80 | TYRO3 | 0.54974295 |
81 | SGK3 | 0.54898913 |
82 | MAP3K1 | 0.54676403 |
83 | SIK3 | 0.53995078 |
84 | GRK7 | 0.53921981 |
85 | BRSK1 | 0.53763522 |
86 | MAP3K11 | 0.53545175 |
87 | FGFR2 | 0.51083836 |
88 | PDK1 | 0.50623141 |
89 | LMTK2 | 0.48521209 |
90 | CAMK2G | 0.48273360 |
91 | MAP2K1 | 0.45994873 |
92 | PDPK1 | 0.43950795 |
93 | PRKCZ | 0.43802791 |
94 | RPS6KA3 | 0.41152117 |
95 | CAMK1G | 0.40897974 |
96 | ADRBK1 | 0.40326872 |
97 | MAPK10 | 0.39997772 |
98 | WNK3 | 0.39848616 |
99 | ROCK2 | 0.39269832 |
100 | MARK2 | 0.38656833 |
101 | WNK1 | 0.36856860 |
102 | TAOK1 | 0.36656344 |
103 | MAP3K7 | 0.35504740 |
104 | CAMK4 | 0.35311356 |
105 | PRKCA | 0.35234099 |
106 | FYN | 0.33756272 |
107 | BCR | 0.33732957 |
108 | DAPK3 | 0.32837402 |
109 | PDK4 | 0.32705278 |
110 | PDK3 | 0.32705278 |
111 | PRKACA | 0.32550716 |
112 | CSNK1D | 0.30874153 |
113 | PRKCB | 0.29701027 |
114 | ERBB2 | 0.29022448 |
115 | PRKG1 | 0.26833192 |
116 | MAPKAPK5 | 0.26207585 |
117 | TESK1 | 0.25545779 |
118 | MAPK8 | 0.25393685 |
119 | CSNK1E | 0.25382250 |
120 | RPS6KB1 | 0.24450375 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.16966902 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.82364688 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.93585848 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.89316625 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.71360969 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.66256343 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.65881990 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.57698416 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50730657 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43066307 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.19843009 |
12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.19322300 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19122714 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15909813 |
15 | Taste transduction_Homo sapiens_hsa04742 | 2.02772793 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 2.02463905 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.87245311 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85633951 |
19 | Renin secretion_Homo sapiens_hsa04924 | 1.85013171 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75051651 |
21 | Long-term depression_Homo sapiens_hsa04730 | 1.70953165 |
22 | Phototransduction_Homo sapiens_hsa04744 | 1.69808409 |
23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69654593 |
24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61917101 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61181076 |
26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52972610 |
27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52531162 |
28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40207329 |
29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35389326 |
30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32692576 |
31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.27978603 |
32 | Gap junction_Homo sapiens_hsa04540 | 1.26796984 |
33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25630185 |
34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23823087 |
35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19553588 |
36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17844154 |
37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17135892 |
38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16909174 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13059067 |
40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10176066 |
41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00573959 |
42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00308360 |
43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00286523 |
44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97510625 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92572597 |
46 | Glioma_Homo sapiens_hsa05214 | 0.91841792 |
47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89412041 |
48 | Axon guidance_Homo sapiens_hsa04360 | 0.88961739 |
49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88821822 |
50 | Melanogenesis_Homo sapiens_hsa04916 | 0.87774572 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81524053 |
52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81421053 |
53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81129643 |
54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79696176 |
55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79103002 |
56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73924748 |
57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66901164 |
58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66328267 |
59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65396093 |
60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65036045 |
61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62241901 |
62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60932629 |
63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60766033 |
64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60338000 |
65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56045837 |
66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54130722 |
67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53616101 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51829786 |
69 | Alcoholism_Homo sapiens_hsa05034 | 0.51368293 |
70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49803822 |
71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49699021 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49062826 |
73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48382662 |
74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47226739 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44939362 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43666498 |
77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43101835 |
78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41956126 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40943005 |
80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39134265 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.38366089 |
82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38067137 |
83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37410259 |
84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37005669 |
85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36490167 |
86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35592354 |
87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.33732725 |
88 | Bile secretion_Homo sapiens_hsa04976 | 0.32847191 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.31883602 |
90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31740132 |
91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31228803 |
92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31211779 |
93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31133858 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31106560 |
95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30930129 |
96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30692555 |
97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30547181 |
98 | Prion diseases_Homo sapiens_hsa05020 | 0.30409630 |
99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.29210577 |
100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26093986 |
101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25619455 |
102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25308115 |
103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25280535 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25225760 |
105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24881285 |
106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23607789 |
107 | Phagosome_Homo sapiens_hsa04145 | 0.23328242 |
108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22602003 |
109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19467430 |
110 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17144347 |
111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.14192307 |
112 | Tight junction_Homo sapiens_hsa04530 | 0.14161568 |
113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.14094463 |
114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13688153 |